{"product_id":"pt","title":"PT","description":"\u003cp\u003e⭐️⭐️⭐️⭐️⭐️ **PT-141 PRODUCT REVIEW**\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003ePT-141, also known as **bremelanotide**, has attracted attention for its research involving **sexual desire and arousal**.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e### 🔬 WHAT DOES PT-141 DO?\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003ePT-141 activates melanocortin receptors, including MC3R and MC4R, which are involved in pathways associated with sexual behavior and desire. The precise mechanism by which bremelanotide improves symptoms of low sexual desire is not fully understood.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e### 📚 WHAT DO THE STUDIES SHOW?\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThe strongest clinical evidence comes from studies in **premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)**.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eTwo large Phase 3 randomized, double-blind, placebo-controlled trials included **1,267 women**. Compared with placebo, bremelanotide produced statistically significant improvements in measures of sexual desire and reductions in distress associated with low sexual desire.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eA separate randomized dose-finding study involving **327 women** also found improvements in sexual-function measures and satisfying sexual events compared with placebo.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eResearch has also examined how melanocortin receptor activation affects sexual processing in the brain. One randomized crossover study found increased sexual desire for up to 24 hours after administration compared with placebo.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e### ⚠️ IMPORTANT TO KNOW\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThe FDA-approved use of bremelanotide is specifically for **acquired, generalized HSDD in premenopausal women**. The clinical evidence should not be interpreted as proof that PT-141 will increase sexual desire in everyone.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCommon adverse effects reported in clinical studies include **nausea, flushing, and headache**.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e**PT-141 — research focused on the melanocortin system, sexual desire, and sexual function.**\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eIndividual responses can vary. Anyone considering bremelanotide should review its risks, contraindications, and approved indications with a qualified healthcare professional.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Pure Quality Pep","offers":[{"title":"Default Title","offer_id":47730565546068,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0708\/3438\/9076\/files\/rn-image_picker_lib_temp_b2350b36-5e3a-4459-b58b-e2708dc04e2e.png?v=1790354765","url":"https:\/\/www.pqpeptides.com\/products\/pt","provider":"Pure Quality Pep","version":"1.0","type":"link"}